091990.KQ Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (15 Dec 2023 @ 01:30):

Celltrion Healthcare Co., Ltd. engages in the manufacture, processing, and sale of biosimilar and biological medicines to patients around the world. Its products include Remsima, a monoclonal antibody biosimilar that is used for rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis, adult Crohn's disease, Crohn's disease in children, psoriasis, and psoriatic arthritis; Truxima, which is used for lymphoma, chronic lymphocytic leukemia, Wegener's granulomatosis and microscopic polyangiitis, and rheumatoid arthritis; Herzuma that is used for metastatic breast cancer, early breast cancer, and metastatic gastric cancer; and Remsima SC, which is used for rheumatoid arthritis...

Stats
Today's Volume	0.00
Average Volume	646 242
Market Cap	10 736.44B
EPS	KRW0 ( 2024-03-18 )
Next earnings date	( KRW0 ) 2024-05-10
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW1 815.66 (2.39%)

Volume Correlation

Long: 0.17 (neutral)

Short: 0.93 (very strong)

Signal:(54.861) Expect same movement, but be aware

Celltrion Healthcare Co., Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Celltrion Healthcare Co., Correlation - Currency/Commodity

0.54
( weak )

0.49
( neutral )

-0.31
( neutral )

0.59
( weak )

-0.13
( neutral )

-0.12
( neutral )

Celltrion Healthcare Co., Financials

Annual	2022
Revenue:	KRW1 972.19B
Gross Profit:	KRW561.75B (28.48 %)
EPS:	KRW912.03

Q3	2023
Revenue:	KRW647.58B
Gross Profit:	KRW157.37B (24.30 %)
EPS:	KRW281.06

Q2	2023
Revenue:	KRW525.80B
Gross Profit:	KRW150.90B (28.70 %)
EPS:	KRW109.97

Q1	2023
Revenue:	KRW503.56B
Gross Profit:	KRW153.18B (30.42 %)
EPS:	KRW336.92

Financial Reports:

No articles found.

Celltrion Healthcare Co.,